A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease

scientific article published on 28 January 2019

A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.OPHTHA.2019.01.024
P698PubMed publication ID30703441

P2093author name stringJoseph B Ciolino
Gail L Torkildsen
Philipp Steven
George W Ousler
Michael Beckert
John D Lonsdale
Sonja Krösser
Helen R Moreira
David L Wirta
Garrit Jentsch
P433issue6
P921main subjectcyclosporineQ367700
eye diseaseQ3041498
P304page(s)792-800
P577publication date2019-01-28
P1433published inOphthalmologyQ7098109
P1476titleA Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease
P478volume126

Reverse relations

cites work (P2860)
Q90615647A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain
Q89939043A Review of Topical Cyclosporine A Formulations-A Disease-Modifying Agent for Keratoconjunctivitis Sicca
Q89536542Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies

Search more.